List
Osteoarthritis (OA) is a prevalent whole-joint disease that requires effective disease-modifying therapies. Intra-articular platelet-rich plasma (PRP) injections offer a minimally invasive treatment option, but face two coupled challenges: premature ex vivo activation causes rapid growth-factor release before injection, and the inflamed, protease-rich synovial microenvironment accelerates their subsequent degradation.
Source: ScienceDirect

